A breadth of literature has established the link between lower BDNF levels in individuals diagnosed with neurodegenerative disorders such as Huntington’s disease (HD), Alzheimer’s disease (AD), and multiple sclerosis (MS) [11]. The gene discussed is BDNF; the disease is myeloid sarcoma.